Central Garden & Pet - CENT Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Central Garden & Pet in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CENT shares.
View CENT analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 12-month price targets for Central Garden & Pet's shares. Their CENT share price forecasts range from $50.00 to $60.00. On average, they predict the company's share price to reach $55.00 in the next year. This suggests a possible upside of 45.9% from the stock's current price.
View analysts price targets for CENT or view top-rated stocks among Wall Street analysts.

Central Garden & Pet's stock was trading at $52.63 at the start of the year. Since then, CENT shares have decreased by 28.4% and is now trading at $37.69.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 28th 2022.
View our CENT earnings forecast.

Central Garden & Pet (NASDAQ:CENT) announced its earnings results on Wednesday, August, 3rd. The company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.26 by $0.13. The company had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $993.37 million. Central Garden & Pet had a trailing twelve-month return on equity of 11.86% and a net margin of 4.48%.

Central Garden & Pet updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share (EPS) guidance of $2.75- for the period, compared to the consensus earnings per share estimate of $2.82. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other Central Garden & Pet investors own include Skechers U.S.A. (SKX), General Electric (GE), Scotts Miracle-Gro (SMG), Zoetis (ZTS), Bunge (BG), Brinker International (EAT), Kroger (KR), Pfizer (PFE), Domtar (UFS) and Verizon Communications (VZ).

Central Garden & Pet trades on the NASDAQ under the ticker symbol "CENT."

Central Garden & Pet's stock is owned by a number of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.76%), State Street Corp (0.70%), Renaissance Technologies LLC (0.54%), Northern Trust Corp (0.36%), Assenagon Asset Management S.A. (0.17%) and Principal Financial Group Inc. (0.11%). Insiders that own company stock include Brooks Pennington III, Daniel P Myers, George A Yuhas, Howard Machek, John D Walker III, John D Walker III, John Edward Hanson, John Ranelli, Nicholas Lahanas, Thomas J Colligan and Timothy P Cofer.
View institutional ownership trends.

Shares of CENT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CENT stock can currently be purchased for approximately $37.69.

Central Garden & Pet (NASDAQ:CENT) has a market capitalization of $2.05 billion and generates $3.30 billion in revenue each year. The company earns $151.75 million in net income (profit) each year or $2.76 on an earnings per share basis.

The company employs 7,000 workers across the globe.

Central Garden & Pet's mailing address is 1340 TREAT BOULEVARD SUITE 600, WALNUT CREEK CA, 94597. The official website for the company is www.central.com. The company can be reached via phone at (925) 948-4000, via email at fedelmann@central.com, or via fax at 302-636-5454.